Company B.braun Pharmaceuticals Sa with Fiscal Code 9307999
recorded a turnover of 2024 of
9.962.610,
with a net profit of
-934.191
and having an average number of employees of
170.
The company operates in the field of Fabricarea produselor farmaceutice de bază having the NACE code 2110.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
B.braun Pharmaceuticals Sa
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
8.118.883
8.108.385
8.114.061
8.604.730
9.906.711
9.078.983
9.226.116
11.167.728
11.325.151
9.962.610
Total Income - EUR
8.356.713
8.504.070
8.937.525
9.064.109
10.743.457
9.501.684
10.081.411
26.737.952
15.908.775
12.404.496
Total Expenses - EUR
7.796.134
7.844.898
8.519.903
8.897.931
12.278.971
10.867.401
11.812.025
29.033.908
16.481.808
13.338.687
Gross Profit/Loss - EUR
560.579
659.172
417.622
166.179
-1.535.514
-1.365.717
-1.730.614
-2.295.956
-573.033
-934.191
Net Profit/Loss - EUR
440.405
533.073
286.205
102.406
-1.564.787
-1.365.717
-1.730.614
-2.295.956
-573.033
-934.191
Employees
156
163
169
195
241
231
181
181
170
170
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales decreased by -11.5%, from 11.325.151 euro in the year 2023, to 9.962.610 euro in 2024.
Check the financial reports for the company - B.braun Pharmaceuticals Sa
Financial Rating - B.BRAUN PHARMACEUTICALS SA
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - B.braun Pharmaceuticals Sa
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - B.braun Pharmaceuticals Sa
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - B.braun Pharmaceuticals Sa
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
B.braun Pharmaceuticals Sa - CUI 9307999
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
6.512.755
7.927.476
8.711.741
26.881.217
39.397.188
45.780.712
48.956.765
33.139.615
28.924.963
29.324.008
Current Assets
5.164.266
5.222.656
12.479.785
5.929.579
4.342.260
3.416.107
5.028.320
21.555.390
8.666.660
5.825.819
Inventories
962.738
1.113.751
1.177.033
1.096.513
1.420.834
1.521.777
1.480.238
1.514.712
1.500.883
1.404.684
Receivables
3.529.639
3.519.074
1.792.638
4.397.226
2.405.121
1.504.836
3.297.502
19.698.890
6.668.830
4.107.813
Cash
671.889
589.831
9.510.114
435.840
516.305
389.494
250.580
341.788
496.947
313.322
Shareholders Funds
2.949.747
4.550.954
19.732.895
19.473.167
17.415.992
13.897.435
26.557.727
24.344.120
23.697.265
22.298.337
Social Capital
962.990
953.169
15.909.785
15.617.812
15.315.356
14.337.655
28.789.555
28.878.875
28.791.301
28.630.394
Debts
8.601.822
8.468.883
1.396.240
13.296.330
26.263.946
35.545.692
27.385.203
30.228.589
14.017.763
12.645.270
Income in Advance
0
0
0
0
0
7.260
13.752
10.906
5.744
7.129
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"2110 - 2110"
CAEN Financial Year
2110
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
5.825.819 euro in 2024 which includes Inventories of
1.404.684 euro, Receivables of
4.107.813 euro and cash availability of
313.322 euro.
The company's Equity was valued at
22.298.337 euro, while total Liabilities amounted to
12.645.270 euro.
Equity decreased by -1.266.490 euro, from 23.697.265 euro in 2023, to 22.298.337 in 2024.
The Debt Ratio was 36.2% in the year 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - B.braun Pharmaceuticals Sa